Recruiting Neuropathy Studies in Columbia
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
The main purpose of this study is to compare empasiprubart and IVIg in adult patients with MMN. The study consists of a double-blinded part A (empasiprubart, IVIg) and an open-label part B (empasiprub...
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
CIDP is an autoimmune disease. This means that the body's germ fighting (immune) system attacks itself. In CIDP, the immune system attacks the protective covering around the nerves called myelin. Over...
About Neuropathy Clinical Trials in Columbia
Neuropathy refers to damage or dysfunction of peripheral nerves, causing weakness, numbness, and pain, typically in the hands and feet. Diabetes is the most common cause, but it can also result from infections, injuries, and autoimmune conditions. Treatment focuses on managing the underlying cause and pain relief.
There are currently 2 neuropathy clinical trials recruiting participants in Columbia, SC. These studies are seeking a combined 151 participants. Research is being sponsored by argenx, Takeda. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuropathy Clinical Trials in Columbia — FAQ
Are there neuropathy clinical trials in Columbia?
Yes, there are 2 neuropathy clinical trials currently recruiting in Columbia, SC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbia research site will contact you about next steps.
Are clinical trials in Columbia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbia studies also compensate for your time and travel.
What neuropathy treatments are being tested?
The 2 active trials in Columbia are testing new therapies including novel drugs, biologics, and treatment approaches for neuropathy.
Data updated March 2, 2026 from ClinicalTrials.gov